Revolutionizing AI in drug discovery via innovative molecular representation paradigms

ReMINDER aims to revolutionize drug discovery by developing novel molecular representations for AI, enhancing model capabilities and solving complex chemical challenges.

Subsidie
€ 1.494.006
2023

Projectdetails

Introduction

Artificial intelligence (AI) in the form of deep learning is driving unprecedented progress in numerous fields, e.g., for protein structure prediction and organic reaction planning. In drug discovery and chemical biology, such progress is an evolution rather than a revolution: several tasks still await to be solved by AI, e.g., accurate structure-activity and activity-cliff prediction, and design of structurally innovative chemical matter.

Current Challenges

Increasingly complex deep learning approaches are leading to progressively smaller gains in model capabilities, calling for a revolution in AI for drug discovery. The springboard for this project is a striking observation: while novel deep learning algorithms are in continuous development, the input raw molecular representations they rely on (e.g., SMILES strings and molecular graphs) have not considerably changed in the last four decades, limiting the amount and quality of chemical information learnable by AI.

Potential for Improvement

The potential of capturing more sophisticated chemical information better into a new molecular language is still untapped and bears promise to revolutionize molecular AI. ReMINDER will break with traditional approaches and shift the object of study from increasingly complex algorithms to novel molecular representation paradigms for AI.

Objectives of ReMINDER

ReMINDER will be an agent of change in the molecular AI landscape by developing a new representation framework at the interface between method development and experimental validation. ReMINDER will disrupt the potential of AI to:

  1. Navigate complex structure-activity landscapes,
  2. Design innovative bioactive molecules from scratch,
  3. Leverage binding pocket information for molecule discovery.

Conclusion

By transforming the chemical information captured for AI, we open opportunities to develop more efficient models and solve open scientific challenges. ReMINDER will create the basis for exciting new technology in the field of deep learning for drug discovery and chemistry at large.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.494.006
Totale projectbegroting€ 1.494.006

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2027
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • TECHNISCHE UNIVERSITEIT EINDHOVENpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Synergy ...

Deep learning analysis of imaging and metabolomic data to accelerate antibiotic discovery against antimicrobial resistance

AI4AMR aims to revolutionize antibiotic discovery by using advanced AI and multi-dimensional data analysis to identify novel antibiotics and their mechanisms of action against antimicrobial resistance.

€ 10.968.734
ERC Starting...

Deep learning of chemical reactions

This project aims to develop advanced deep learning frameworks for modeling organic and enzymatic reactions to enhance predictions of selectivity and enable sustainable synthesis.

€ 1.499.285
ERC Starting...

Continual and Sequential Learning for Artificial Intelligence

Develop a Continual and Sequential Learning AI that integrates RL with advanced data gathering to autonomously adapt and explore in dynamic environments for scientific breakthroughs.

€ 1.259.375
ERC Advanced...

Automated, miniaturized and accelerated drug discovery: AMADEUS

AMADEUS is an automated platform for rapid, sustainable drug discovery that synthesizes thousands of small molecules daily, optimizing processes through AI to reduce costs and enhance accessibility.

€ 3.409.401
ERC Consolid...

Integrative, AI-aided Inference of Protein Structure and Dynamics

The project aims to develop bAIes, a novel modeling approach combining AI, experimental data, and molecular simulations to enhance protein structure and dynamics characterization, particularly for SARS-CoV-2.

€ 2.932.775

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

Drug Discovery Intelligence

Het project ontwikkelt een AI-gestuurde softwareapplicatie om risico's in de medicijnontwikkeling te verminderen door het voorspellen van therapeutische targets en drug-target interacties.

€ 20.000
EIC Pathfinder

QUANTUM-TOX - Revolutionizing Computational Toxicology with Electronic Structure Descriptors and Artificial Intelligence

This project aims to revolutionize computational toxicology by developing interpretable quantum mechanics-based descriptors (ESigns) for accurate toxicity predictions across the entire chemical space.

€ 1.994.770
EIC Pathfinder

Reaction robot with intimate photocatalytic and separation functions in a 3-D network driven by artificial intelligence

CATART aims to develop autonomous reaction robots using AI and 3-D quantum dot networks to efficiently mimic natural chemical production, enhancing productivity and sustainability in the chemical industry.

€ 2.871.775
Mkb-innovati...

AI to render the best clinical trial design for a novel RNA therapy.

Het ANTENA-project ontwikkelt een AI-platform om de optimale klinische studiepopulatie voor een nieuwe RNA-medicatie te identificeren, met als doel kosten en risico's van klinische proeven te verlagen.

€ 199.700